This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| paralytic shellfish poisoning | |
|---|---|
| Name | Paralytic shellfish poisoning |
| Field | Toxicology, Emergency medicine, Epidemiology |
| Symptoms | Paralysis, paresthesia, nausea, vomiting, dyspnea |
| Complications | Respiratory failure, death |
| Onset | Minutes to hours after ingestion |
| Duration | Hours to days |
| Causes | Saxitoxin and related neurotoxins from harmful algal blooms |
| Risks | Consumption of contaminated bivalve molluscs, algal bloom exposure |
| Prevention | Shellfish monitoring, harvesting closures, public advisories |
paralytic shellfish poisoning
Paralytic shellfish poisoning is an acute toxin-mediated syndrome caused by ingestion of bivalve molluscs contaminated with saxitoxin-group neurotoxins produced during harmful algal blooms. It presents with rapid onset neurologic and gastrointestinal symptoms and can progress to life-threatening respiratory paralysis requiring ventilatory support. Management is primarily supportive and public-health actions focus on monitoring, shellfish bed closures, and risk communication.
Paralytic shellfish poisoning results from accumulation of saxitoxins in filter-feeding shellfish during harmful algal blooms associated with dinoflagellates and cyanobacteria. Historical and contemporary outbreaks have prompted responses from agencies such as the United States Food and Drug Administration, Centers for Disease Control and Prevention, World Health Organization, and national marine authorities in countries including Canada, Japan, Spain, Australia, and Chile. Research on marine toxin ecology and public health has involved institutions like the Woods Hole Oceanographic Institution, Scripps Institution of Oceanography, National Oceanic and Atmospheric Administration, and university centers at University of California, Santa Cruz, Dalhousie University, and University of Tokyo. Interdisciplinary collaboration often includes toxicologists, emergency physicians, marine biologists, and public health officials.
The proximate cause is ingestion of saxitoxin and related paralytic shellfish toxins synthesized by dinoflagellates such as Alexandrium tamarense, Gymnodinium catenatum, and Pyrodinium bahamense, and sometimes cyanobacterial strains implicated in freshwater events. Bloom dynamics are modulated by oceanographic and climatic factors studied by groups like Intergovernmental Panel on Climate Change researchers and modeled in programs at National Aeronautics and Space Administration and European Space Agency satellite initiatives. Saxitoxins act by blocking voltage-gated sodium channels on neuronal membranes, blocking action potential propagation—a mechanism elucidated in electrophysiology laboratories at institutions such as Max Planck Society centers and the Howard Hughes Medical Institute. Structure–activity relationships have been characterized by chemists affiliated with Royal Society of Chemistry, American Chemical Society, and pharmacology groups at National Institutes of Health laboratories.
Patients typically present within 30 minutes to a few hours with oral paresthesias, numbness, nausea, vomiting, ataxia, and cranial nerve dysfunction that can progress to descending paralysis. Critical care protocols for toxin-induced respiratory compromise reference guidelines from organizations such as the American College of Emergency Physicians, Society of Critical Care Medicine, and national trauma systems including National Health Service (England) critical care networks. Diagnostic approaches combine clinical history of shellfish exposure, toxin assays using high-performance liquid chromatography and mass spectrometry developed in analytical laboratories at Massachusetts Institute of Technology and University of Oxford, and rapid tests validated by agencies like the Food and Agriculture Organization and European Food Safety Authority. Differential diagnosis may involve consultations with neurologists trained at centers such as Mayo Clinic, Johns Hopkins Hospital, and Cleveland Clinic.
There is no specific antidote; management is supportive with airway protection, oxygenation, and mechanical ventilation when necessary, following standards from American Heart Association advanced life support and European Resuscitation Council guidelines. Early recognition and transfer to intensive care units in hospitals like Mount Sinai Health System or regional referral centers improve outcomes. Experimental therapeutics and passive immunotherapies have been explored in preclinical programs at institutions such as The Scripps Research Institute and pharmaceutical research divisions at Pfizer and Roche. Rehabilitation after recovery may involve multidisciplinary teams affiliated with American Physical Therapy Association and neurorehabilitation centers including Kessler Institute for Rehabilitation.
Outbreaks have been documented worldwide, with notable events in regions served by the Gulf of Maine fisheries, the Pacific Northwest, New England, Galicia (Spain), and parts of Southeast Asia. Surveillance is coordinated by national laboratories and reference centers including Public Health England, Health Canada, and the Australian Institute of Marine Science. Climatic phenomena such as El Niño–Southern Oscillation and long-term ocean warming influence bloom frequency, with modeling contributions from IPCC authors and oceanographers at Lamont–Doherty Earth Observatory. Economic impacts affect commercial fisheries, aquaculture operations, and tourism sectors overseen by agencies like the National Oceanic and Atmospheric Administration and regional fishery management councils.
Prevention relies on systematic shellfish bed monitoring programs, closure protocols, and public advisory systems implemented by bodies such as the National Shellfish Sanitation Program, European Commission, and national ministries of health and fisheries. Analytical capacity for toxin detection has advanced through collaborations among laboratories at University of Washington, University of British Columbia, University of Bergen, and private testing firms. Citizen science initiatives and outreach coordinate with organizations like Monterey Bay Aquarium and marine conservation NGOs. Technology-driven surveillance leverages satellite remote sensing by NASA and forecasting efforts by regional oceanographic centers such as Pacific Islands Fisheries Science Center.
Regulatory frameworks establish permissible limits for paralytic shellfish toxins and mandates for testing, closure, and labeling; such frameworks are enforced by agencies including the European Food Safety Authority, U.S. Food and Drug Administration, and national food safety authorities in Japan and Chile. Economic assessments involve stakeholders from commercial associations like the National Fisheries Institute, aquaculture companies, and regional development agencies. International trade and market access implicate standards from the World Trade Organization and guidance from the Food and Agriculture Organization. Risk communication strategies draw on best practices from public health institutions such as Centers for Disease Control and Prevention and international collaborations among research consortia.
Category:Marine toxins